SITC Resource Library

• Moderator: Ignacio Melero, MD, PhD — Foundation for Applied Medical Research (FIMA) (Expert Panel Chair)
• Peter R. Galle, MD, PhD — University of Mainz Medical Center (Expert Panel Member)
• Bruno Sangro, MD, PhD — Universidad de Navarra (Expert Panel Member)

• Appropriate diagnostics and biomarker testing for a patient with HCC being considered for immunotherapy based on the expert panel recommendations in the SITC Clinical Practice Guideline (CPG)
• Immunotherapy treatments for HCC effectively and appropriately according to the recommendations in the CPG
• Patterns of response to immunotherapy in order to appropriately monitor and manage patients with HCC during treatment
• Considerations and available tools to assess and support patient quality of life during immunotherapy treatment for HCC

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org or check out our free CPG mobile app.

This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.

Please note that the on-demand webinar is not available for continuing education credits